Position history for FMR LLC's holdings in CRINETICS PHARMACEUTICALS IN
FMR LLC holds 15.8M shares of CRNX (CRINETICS PHARMACEUTICALS IN), worth $572.4M as of 2026-Q1. The position was increased (+10.3% shares). CRNX represents 0.0% of FMR LLC's portfolio.
Current Value
$572.4M
Current Shares
15.8M
Total Value Change
+$115.9M
Total Shares Change
+6.8M
Other major holders of CRNX: BNP PARIBAS FINANCIAL MARKETS, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, VANGUARD GROUP INC
Increased |
| 15.8M |
+10.3% |
| $572.4M |
| 0.0% |
| $40.12 |
35 |
| 2025-Q4 | Increased | 14.3M | +0.8% | $665.4M | 0.0% | $47.39 | 32 |
| 2025-Q3 | Increased | 14.2M | +0.4% | $590.9M | 0.0% | $43.51 | 32 |
| 2025-Q2 | Increased | 14.1M | +0.7% | $406.3M | 0.0% | $29.96 | 31 |
| 2025-Q1 | Increased | 14M | +57.2% | $470.6M | 0.0% | $34.73 | 45 |
| 2024-Q4 | New | 8.9M | - | $456.5M | 0.0% | $50.67 | 43 |